A new Supernus Pharmaceuticals medical device that continuously administers an old Parkinson’s disease drug is now FDA approved, giving patients another way to manage the motor control symptoms that ...
Stanford University School of Medicine neurologist Helen Bronte-Stewart is shown working with a Parkinson's disease patient during clinical trials of a new device to control tremors and other symptoms ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. It’s improving quality of life. Parkinson’s ...
Feb 4 (Reuters) - The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' (SUPN.O), opens new tab drug-device combination to treat movement-related symptoms of Parkinson's disease ...
A pioneering device could help patients with the incurable neurological disease Parkinson’s walk again, researchers suggest. Nearly 150,000 people in the UK suffer from Parkinson’s disease, a ...
An estimated 1.1 million Americans are currently living with Parkinson’s disease—a neurodegenerative condition that causes tremors, limb stiffness, and mobility issues. Despite how common Parkinson’s ...
MedRhythms, a Portland-based digital health startup founded in 2013, has won approval from the U.S. Food and Drug Administration for a device to help Parkinson’s disease patients improve their walking ...
BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...
A long-term goal within neuroscience has been to develop a non-invasive way to influence brain function. Such a technology could shed light on the vital organ’s operations—and one day, it could even ...
ST. PAUL, Minn., March 21 (UPI) --Parkinson's disease patients and advocates are marking the start of a new era for treatment of the illness, as a doctors deploy a breakthrough neurological device for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results